Boys Arnold & Co Portfolio holdings
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$33.8M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$20.1M |
| 3 |
iShares Intermediate Government/Credit Bond ETF
GVI
|
+$11.5M |
| 4 |
Apple
AAPL
|
+$10.7M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$10.5M |
Top Sells
| 1 |
BSCF
CLAYMORE GUGGENHEIM BULLETSHARES 2015 CORP BD ETF
BSCF
|
+$1.02M |
| 2 |
Eli Lilly
LLY
|
+$556K |
| 3 |
GSK
GSK
|
+$529K |
| 4 |
GAP
The Gap Inc
GAP
|
+$519K |
| 5 |
Franklin Resources
BEN
|
+$501K |
Sector Composition
| 1 | Consumer Discretionary | 12.24% |
| 2 | Healthcare | 11.17% |
| 3 | Industrials | 8.83% |
| 4 | Financials | 8.32% |
| 5 | Technology | 8.25% |
Similar funds
Boys Arnold & Co's Q4 2015 Portfolio in Review
As of Q4 2015, Boys Arnold & Co held 234 positions worth $918M, up 91% from $480M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Boys Arnold & Co deployed $415M of net new capital in Q4 2015, opening 9 new positions and adding to 196 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 26,358 shares worth $2.08M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Eli Lilly, an estimated $556K trimmed.
- Boys Arnold & Co's largest Q4 2015 buy was Vanguard Short-Term Corporate Bond ETF: 26,358 shares worth $2.08M.
- Boys Arnold & Co added most to Lowe's Companies in Q4 2015, an estimated $33.8M increase.
- Boys Arnold & Co's biggest Q4 2015 reduction was Eli Lilly, cutting an estimated $556K.
- Boys Arnold & Co fully exited CLAYMORE GUGGENHEIM BULLETSHARES 2015 CORP BD ETF in Q4 2015, selling an estimated $1.02M.
- Boys Arnold & Co's ten largest holdings make up 29% of its $918M portfolio in Q4 2015.
- Boys Arnold & Co opened 9 new positions and closed 20 in Q4 2015.
- Boys Arnold & Co's portfolio value rose 91% quarter-over-quarter to $918M.
Based on Boys Arnold & Co's 13F filing for Q4 2015, filed 5 Feb 2016.